BETA: Please send your feedback!
Natera
NTRA:NAS
Biotechnology
$2.79bn
SMALL cap
$39.85
(-0.01%)
2.08%
since start of 2019
-19.73
- 1
- 3
- 1
- —
- —
- 4
- 1
- 1
- —
- —
- —
- 1
-
CF
-
PP
-
WC
-
DP
-
CH
-
ES
-
WS
-
CG
-
EP
-
CM
-
FL
-
GD
- —
- 1
- 2
- 3
- 4
- 5
About
Biotechnology
Founded 2003
Natera, Inc. engages in the discovery, development, and commercialization of genetic testing services. It offers Panorama Non-Invasive Prenatal Test; Horizon Carrier Screening; Spectrum Pre-implantation Genetic Screening and Spectrum Pre-implantation Genetic Diagnosis; Anora Products of Conception; and Non-Invasive Paternity Testing. The company was founded by Matthew Rabinowitz and Jonathan Sheena in November 2003 and is headquartered in San Carlos, CA.
website
Headquarters
Executives
| Name | Title | Gender |
| Matthew Rabinowitz, PhD | Chairman, President & Chief Executive Officer | Male |
| Jonathan Sheena | Director & Chief Technology Officer | Male |
| Daniel Rabinowitz | Secretary & General Counsel | Male |
| Mike Brophy, MBA | CFO, Director & Head-Investor Relations | Male |
| Damon Silvestry | Vice President-Operations | Male |
| Michael C. Little, PhD | Senior Vice President-Research & Development | Male |
| Joshua Leichter | Vice President-Legal & Corporate Affairs | Male |
| Cheng-Ho Lin, PhD | Chief Scientific Officer | null |
Mindful Investing Summary
- —
- 1
- 2
- 3
- 4
- 5
-
Carbon Footprint — N/A
-
Pollution Prevention — N/A
-
Water Conservation — N/A
-
Data & Privacy Protection — N/A
-
Consumer Health, Wellness & Safety — N/A
-
Employee Ownership, Satisfaction, Benefits & Pay — N/A
-
Workplace Health and Safety — N/A
-
Integrity of Corporate Governance — N/A
-
Ethical Practices — N/A
-
Usage of Conflict Materials — N/A
-
Forced Labor — N/A
-
Diversity of Corporate Leadership 2
Natera - Competitors and Related Companies
How Natera stacks up to its peers in the Biotechnology industry or with competing business segments.
Natera
NTRA:NAS
Biotechnology
$2.79bn
SMALL cap
$39.85
(-0.01%)
2.08%
since start of 2019
-19.73
Paratek Pharmaceuticals
PRTK:NAS
Biotechnology
$103.79mm
SMALL cap
$3.19
(-0.01%)
-0.43%
since start of 2019
-0.83
Prothena
PRTA:NAS
Biotechnology
$361.87mm
SMALL cap
$9.07
(0.73%)
-0.12%
since start of 2019
-4.32
Pluristem Therapeutics
PSTI:NAS
Biotechnology
$59.55mm
MICRO cap
$3.83
(-0.03%)
-0.57%
since start of 2019
-1.32
Vertex Pharmaceuticals
VRTX:NAS
Biotechnology
$49.01bn
LARGE cap
$190.68
(7.15%)
0.16%
since start of 2019
21.96